Clinical Trials

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT04597125 2026-04-15

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

654 enrolled

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT04108208 2026-04-13

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

75 enrolled 9 charts

Prostatic Neoplasms

NCT05348876 2026-03-19

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

50 enrolled

Prostatic Neoplasms

NCT06862219 2026-03-06

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

100 enrolled

Carcinoma, Transitional Cell

NCT04373564 2026-01-22

ODYSSEY

BreastEndocrineGastrointestinalGenitourinaryNET

2,076 enrolled

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT06074510 2025-09-11

MIRROR

274 enrolled

Prostatic Neoplasms

NCT06604442 2025-09-11

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

55 enrolled

Prostatic Neoplasms

NCT04513522 2025-07-11

CheckMate 7C9

101 enrolled 12 charts

Kidney Neoplasms

NCT01673984 2025-05-23

GREAT

27 enrolled 13 charts

Prostatic Neoplasms

NCT05803941 2025-04-24

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

700 enrolled

Prostatic Neoplasms

NCT03641560 2025-04-08

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

52 enrolled 10 charts

Metastatic Castration Resistant Prostate Cancer

NCT02405858 2025-02-03

A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy

51 enrolled

Metastatic Castration-Resistant Prostate Cancer

NCT02918968 2024-12-09

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

206 enrolled 16 charts

Prostatic Neoplasms

NCT02116582 2024-12-06

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

215 enrolled 11 charts

Metastatic Castration-Resistant Prostate Cancer

NCT03035032 2024-11-26

A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

107 enrolled 25 charts

Prostatic Neoplasms

NCT06390111 2024-11-22

ABLE-42

Phase 4 Withdrawn

Urinary Bladder Neoplasms

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

DermatologicEndocrineGenitourinaryNET

337 enrolled 8 charts

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT00953277 2024-08-12

Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

12 enrolled

Prostatic Neoplasms, Peripheral Nerve Injuries

NCT03123406 2024-04-29

ACTIVE

750 enrolled

GenitourinaryHead & Neck

Hyperparathyroidism, Hyperparathyroidism, Secondary, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder

NCT01995513 2023-09-18

PLATO

509 enrolled 18 charts

Prostatic Neoplasms

NCT03971110 2022-12-16

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

9 enrolled

Advanced Prostate Cancer

NCT02982954 2022-11-01

CHECKMATE 920

211 enrolled 21 charts

Carcinoma, Renal Cell

NCT02596035 2022-10-27

CheckMate 374

197 enrolled 16 charts

Carcinoma, Renal Cell

NCT02485691 2022-05-27

CARD

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT05304169 2022-03-31

PRIZE

48 enrolled

Prostatic Neoplasms

NCT02726009 2021-12-15

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

230 enrolled

Prostatic Neoplasms

NCT00414765 2021-06-08

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

DermatologicGenitourinary

26 enrolled 7 charts

Carcinoma, Renal Cell, Melanoma

NCT01753297 2020-12-09

PRIORITI

226 enrolled 19 charts

Prostatic Neoplasms

NCT03444766 2020-12-04

Study of Nivolumab for Advanced Cancers in India

100 enrolled 12 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms

NCT01206764 2019-06-24

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

143 enrolled 11 charts

Carcinoma, Renal Cell

NCT02441517 2018-04-19

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

4 enrolled 12 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT01266837 2017-11-14

MARC-2

64 enrolled

Carcinoma, Renal Cell

NCT00063609 2017-09-13

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

200 enrolled

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms

NCT01521715 2017-08-23

FLIPPER

44 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT01514448 2017-07-19

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

29 enrolled 9 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00219271 2017-05-31

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

60 enrolled

Prostatic Neoplasms

NCT01933022 2017-03-09

EFFECT

1 enrolled

Prostatic Neoplasms

NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

BreastGenitourinaryPlasma cellSarcoma

73 enrolled

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

NCT00470834 2017-02-27

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

127 enrolled 13 charts

Prostatic Neoplasms

NCT00237146 2017-02-23

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

38 enrolled

Prostatic Neoplasms

NCT00242554 2017-02-23

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

150 enrolled

Prostatic Neoplasms

NCT00434317 2017-02-23

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

80 enrolled

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

NCT00334139 2017-02-07

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

411 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT02441894 2017-01-24

PEGAZUS

21 enrolled

Prostatic Neoplasms

NCT00375765 2017-01-19

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

40 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT00363311 2017-01-18

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

302 enrolled 37 charts

Prostatic Neoplasms

NCT00172003 2016-11-18

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

50 enrolled

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT00391690 2016-11-18

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

99 enrolled

Prostatic Neoplasms

NCT01649635 2016-07-06

PROSPECTA

45 enrolled